Drug Price Transparency
Drug Price Transparency organizes records from CMS data API into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
| Record | Record Date | Vuga Group | Change Status | Recency Days | Public Significance Score |
|---|---|---|---|---|---|
| Cabenuva | 01/01/2024 | Cabotegravir/Rilpivirine | increased | 972.23 | 100 |
| Cablivi | 01/01/2024 | Caplacizumab-Yhdp | increased | 972.23 | 100 |
| Cablivi | 01/01/2024 | Caplacizumab-Yhdp | increased | 972.23 | 100 |
| Cabometyx | 01/01/2024 | Cabozantinib S-Malate | increased | 972.23 | 100 |
| Cabometyx | 01/01/2024 | Cabozantinib S-Malate | increased | 972.23 | 100 |
| Calcitonin-Salmon* | 01/01/2024 | Calcitonin,Salmon,Synthetic | increased | 972.23 | 100 |
| Calcitonin-Salmon* | 01/01/2024 | Calcitonin,Salmon,Synthetic | increased | 972.23 | 100 |
| Calcitonin-Salmon* | 01/01/2024 | Calcitonin,Salmon,Synthetic | increased | 972.23 | 100 |
| Calquence | 01/01/2024 | Acalabrutinib Maleate | increased | 972.23 | 100 |
| Calquence | 01/01/2024 | Acalabrutinib Maleate | increased | 972.23 | 100 |
| Calquence | 01/01/2024 | Acalabrutinib | increased | 972.23 | 100 |
| Calquence | 01/01/2024 | Acalabrutinib | increased | 972.23 | 100 |
| Camzyos | 01/01/2024 | Mavacamten | increased | 972.23 | 100 |
| Camzyos | 01/01/2024 | Mavacamten | increased | 972.23 | 100 |
| Cancidas | 01/01/2024 | Caspofungin Acetate | increased | 972.23 | 100 |
| Cancidas | 01/01/2024 | Caspofungin Acetate | increased | 972.23 | 100 |
| Caprelsa | 01/01/2024 | Vandetanib | increased | 972.23 | 100 |
| Caprelsa | 01/01/2024 | Vandetanib | increased | 972.23 | 100 |
| Carbaglu | 01/01/2024 | Carglumic Acid | increased | 972.23 | 100 |
| Carbaglu | 01/01/2024 | Carglumic Acid | increased | 972.23 | 100 |
| Carglumic Acid | 01/01/2024 | Carglumic Acid | increased | 972.23 | 100 |
| Carglumic Acid | 01/01/2024 | Carglumic Acid | increased | 972.23 | 100 |
| Cayston | 01/01/2024 | Aztreonam Lysine | increased | 972.23 | 100 |
| Cayston | 01/01/2024 | Aztreonam Lysine | increased | 972.23 | 100 |
| Cerdelga | 01/01/2024 | Eliglustat Tartrate | increased | 972.23 | 100 |
| Cerdelga | 01/01/2024 | Eliglustat Tartrate | increased | 972.23 | 100 |
| Cerezyme | 01/01/2024 | Imiglucerase | increased | 972.23 | 100 |
| Cerezyme | 01/01/2024 | Imiglucerase | increased | 972.23 | 100 |
| Chenodal | 01/01/2024 | Chenodiol | increased | 972.23 | 100 |
| Chenodal | 01/01/2024 | Chenodiol | increased | 972.23 | 100 |
| Cholbam | 01/01/2024 | Cholic Acid | increased | 972.23 | 100 |
| Cholbam | 01/01/2024 | Cholic Acid | increased | 972.23 | 100 |
| Chorionic Gonadotropin | 01/01/2024 | Chorionic Gonadotropin, Human | increased | 972.23 | 100 |
| Chorionic Gonadotropin | 01/01/2024 | Chorionic Gonadotropin, Human | increased | 972.23 | 100 |
| Cibinqo | 01/01/2024 | Abrocitinib | increased | 972.23 | 100 |
| Cibinqo | 01/01/2024 | Abrocitinib | increased | 972.23 | 100 |
| Cimerli | 01/01/2024 | Ranibizumab-Eqrn | increased | 972.23 | 100 |
| Cimerli | 01/01/2024 | Ranibizumab-Eqrn | increased | 972.23 | 100 |
| Cimzia (2 Pack) | 01/01/2024 | Certolizumab PEGol | increased | 972.23 | 100 |
| Cimzia (2 Pack) | 01/01/2024 | Certolizumab PEGol | increased | 972.23 | 100 |
| Cimzia | 01/01/2024 | Certolizumab PEGol | increased | 972.23 | 100 |
| Cimzia | 01/01/2024 | Certolizumab PEGol | increased | 972.23 | 100 |
| Cinqair | 01/01/2024 | Reslizumab | increased | 972.23 | 100 |
| Cinqair | 01/01/2024 | Reslizumab | increased | 972.23 | 100 |
| Cinryze | 01/01/2024 | C1 Esterase Inhibitor | increased | 972.23 | 100 |
| Cinryze | 01/01/2024 | C1 Esterase Inhibitor | increased | 972.23 | 100 |
| Combivent Respimat | 01/01/2024 | Ipratropium/Albuterol Sulfate | increased | 972.23 | 100 |
| Combivent Respimat | 01/01/2024 | Ipratropium/Albuterol Sulfate | increased | 972.23 | 100 |
| Cometriq | 01/01/2024 | Cabozantinib S-Malate | increased | 972.23 | 100 |
| Cometriq | 01/01/2024 | Cabozantinib S-Malate | increased | 972.23 | 100 |